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The Ss locus in the mouse was originally defined by quantitative variation (Ss-H,
high ; Ss-L, low) in a specific serum protein that was detected with a heteroim-
mune antiserum (1) . It was subsequently shown that Ss maps within the H-2
complex between the K andD regions, which code for the major transplantation
antigens (1) . An allotypic variant of the Ss protein, the sex-limited protein (Slp),
was also described (1) . Slp-positive strains are denoted Slpa and Slp-negative
strains are denoted Slpo .
Demant et al . have shown that H-2 haplotype influences the serum levels of
hemolytic complement (C) (2) . Through use of intra-H-2 recombinant lines, the
C determinant was shown to map in the same chromosomal region as the Ss locus
(2) . Male mice of strains that are phenotypically Ss-H, Slpa were found to have
higher levels of C than strains that are Ss-H, Slpo, which in turn have higher
levels than strains that are phenotypically Ss-L .
The experiments described in this communication were designed to determine :
(a) Whether the Ss locus itself or a closely linked gene is responsible for
quantitative differences in C activity ; and (b) what effect the removal of Ss
protein from serum has on hemolytic C activity . A preliminary attempt to answer
the second question by reacting Ss-H serum with anti-Ss antibodies was reported
(2) . However, because of the technique used, it was not possible to determine
whether the observed removal of C activity was the result of secondary C fixation
to antigen-antibody complexes or of the removal of a necessary C component (3) .
Our results nowindicate that the Ss protein itself is a component of the C system .
Materials and Methods
Preparation ofAnti-SsandAnti-Bovine SerumAlbumin (BSA) .
￿
Rabbit anti-Ss wasprepared by
immunizing with partially purified Ss protein derived from a pool of Ss-H serum .The immunization
schedule was as follows : day 0, 1 mg protein in 0.5 ml phosphate-buffered saline (PBS)
intraperitoneally (i.p .) with 0.5 ml Freund's complete adjuvant; day 7, 0.5 mg protein in 0.5 ml PBS
i.p . with 0.5 ml Freund's complete adjuvant ; day 14, 0.25 mg protein in 0.5 ml intravenously ; days 21,
23, and 25, bleedings were taken . The immune serum was absorbed with Ss-L serum at an
approximate ratio of 1 :10 (1 part Ss-L serum : 10 parts immune serum) to remove all contaminating
antibodies detectable by immunodiffusion and immunoelectrophoresis . Rabbit anti-BSA was
prepared following the same immunization schedule described above .
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IgG Separation and Enzymic Digestion.
￿
Immune serum (either anti-Ss or anti-BSA) was first
separated on a DEAF Sephadex A-50 column equilibrated with 0.1 M ethyline diamine, 0.05 M
sodium acetate, pH 8. Antibody-containing fractions were pooled, concentrated, and dialyzed
against 0.1 M sodium phosphate buffer, pH 8. The sample was then fractionated on a 0.1 M phos-
phate-buffered Sephadex G-200 column. Reactive fractions were pooled and concentrated to about
100 mg/ml. This IgG preparation wasthen dialyzed against several changes of0.07 M sodium acetate,
0.05 M sodium chloride, pH 4, for 24 h. For F(ab'), preparation, a portion of this sample was incu-
bated with pepsin in a water bath at 37°C for 18 hr at a ratio of 3 mg enzyme/100 mg protein. At the
end of the digestion period, the sample was adjusted to pH 8 with NaOH and then dialyzed against
phosphate buffer, pH 8. The F(ab'), fragments were purified by passage through Sephadex G-100
equilibrated with 0 .1 M phosphate buffer, pH 8. The control IgG preparation went through the same
sequence as the F(ab'), except that no pepsin was added andthe G-100 passage was omitted. TheIgG
and F(ab'), preparations were concentrated to give levels of antibody reactivity equivalent to the
original antiserum and then dialyzed against 0.1 M tris, 0.15 M NaCl buffer, pH 8. They were then
spun down at 30,000 g for 2 h, aliquoted, and stored at -80°C.
MouseSera.
￿
FortheSs protein-C level correlation experiments, mice were bled from an incision
in the ventral artery of the tail after the mice hadbeen warmed for about 5 min in a glass jar placed
under a 100 W lamp. For the Ss-depletion experiments, the mice were bled from the retro-orbital
sinus. In both instances, the blood was allowed to clot for 30 min at room temperature. After the clot
was rimmed,theblood wasstored at 4°C for 60 min andthen centrifuged at 1,000 gfor 10 min at 4°C.
The serum was collected and kept on ice until 2 h within use.
CFixation Test (4).
￿
C fixation buffer (Oxoid, London, England) wasused throughoutthetest. The
following three reactants were combined and incubated for 45 min at 37°C in aDubnoffshaker-incu-
bator (Dubnoff Precision Scientific, Chicago, Ill.) with 5% CO,: (a) 0.1 ml of "Cr-labeled sheep
erythrocytes (3 x 101 cells/ml); (b) 0.1 ml of rabbit antisheep hemolysin, 1 :100 (Difco Laboratories,
Detroit, Mich.); and (c) 0.1 ml of the reaction mixture to be tested. The test was stopped by adding
cold saline after which the samples were spun down (1, 200 gfor 10 min) andthe supernates counted.
Serum C Assay. Hemolytic titers of serum samples in terms of CH,, units were measured
according to Terry et al. (5) . In cases where serum samples were contaminated with hemoglobin, the
OD values contributed by the contaminant were subtracted from experimental values.
Immunodiffusion Techniques. Radial immunodiffusion plates were set up according to a
technique described earlier (6).
Results and Discussion
Male mice of two inbred strains were individually bled and their serum tested for
hemolytic C activity by the total serum C assay and for Ss reactivity by radial
immunodiffusion. In a group of 11 C3H.OH d mice (Ss-H, Slpa), a significant
positive correlation (0 .82) wasfound. In a group of nine C.SW a mice (Ss-H, Slpo)
a significant positive correlation (0.87) was also found. These significant
correlations found within strains tend to implicate the Ss protein itself rather
than the product of another gene linked to Ss in the H-2-associated quantitative
variation in hemolytic C levels. The positive correlation could conceivably be the
result ofjoint regulation, by an Ss-regiongene product, of both the Ss protein and
a limiting C component. However, if this is so, the high correlation suggests a
very precise and direct regulatory mechanism for the two proteins.
To further explore this relationship, the Ss serum protein was specifically
removed from mouse serum with a pepsin digest of the IgG fraction of anti-Ss.
This anti-Ss [F(ab')2] was employed to avoid any nonspecific C binding to
Ss-anti-Ss complexes. The result of absorption of a constant amount of mouse
serum with varying dilutions of anti-Ss [F(ab')2], as compared with intact
anti-Ss (IgG) is shown in Fig. 1. The two absorbants were used at concentrations





immunodiffusion. The anti-Ss [F(ab')Z ] removed C activity concomitantly with
the removal of Ss reactivity. The anti-Ss (IgG) was somewhat more effective in
removing C activity than the anti-Ss [F(ab') z ], presumably because the anti-Ss
(IgG) when complexed with Ss protein can fix C. Four other experimentswhich
were carriedout analogouslyto theone shown in Fig. 1, gave the identical results.
To demonstrate that the anti-Ss [F(ab') Z ] did not contain residual, C-binding
IgG molecules, the experiment shown in Fig. 2 was performed. This experiment
demonstrated that the anti-Ss [F(ab')z ] complexed with antigen did not fix
rabbit C, in contrast to the anti-Ss (IgG), which fixed considerable amounts. In
this experiment a constant amount ofSs partially purified by G-200 gel filtration
was mixed with varying dilutions of antibody, either anti-Ss (IgG) or anti-Ss
[F(ab') 2 ], and rabbit serum. The same results were obtained in two additional,
identical experiments.
It has been reported that, under certain experimental conditions, precipitates
of F(ab') 2 and antigen can fix significant amounts of guinea pig C, via the
alternate pathway (7). To determine whether F(ab') z-antigen complexes could
fix mouse C in our system, the experiment shown in Fig. 3 was done. In this













Absorption of a constant amount of mouse serum with varying dilutions of anti-Ss
[F(ab') z] or anti-Ss (IgG). Each sample contained 33 Ml of fresh B10.A(5R) mouse serum (8
CHs, units) and33 dal of antibody solution and 33 A1 buffer. Thesamples were kept on ice for 1.5
h before they were added to sensitized sheep erythrocytes. (-), Anti-Ss [F(ab'),] + mouse
serum; (---), anti-Ss (IgG) plus mouse serum; and (- -), concentration of Ss (after absorption









Fixation of rabbit C by partially purified Ss complexed with either anti-Ss [F(ab'),I or
anti-Ss (IgG) . Each sample contained 33 j1 partially purified Ss, 33 Al of serially diluted
antibody solution, and 33 yl of rabbit Csolution (2 CHs, units) . After incubation for 40 min at
37°C, the residual C activity was tested on "Cr-labeled, sensitized sheep erythrocytes. (-),
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FIG. 3.
￿
Fixation of mouseCby anti-BSA [F(ab'), or IgG] complexed with BSA. Each sample
contained 33 ul BSA solution, 33 kl of a solution of serially diluted antibody, and 33 ul of a
solution of fresh mouse serum (2 CH,, units) . Thesamples were incubated at 37°C for 40 min
and then theresidual C activity was tested using "Cr-labeled, sensitized sheep erythrocytes.
(-), Anti-BSA [F(ab'),] plus BSA plus mouse serum; (---), anti-BSA (IgG) plus BSA plus
mouse serum; and (- -), concentration of BSA (after absorption with either F(ab'), or IgG
anti-BSA.
anti-BSA [F(ab')2] or anti-BSA (IgG) and a constant amount of fresh mouse
serum. The concentration ofBSA used in this experiment was equivalent to the
estimated concentration of Ss in an equal Vol of whole serum (50 jug/ml) . The
anti-BSA [F(ab')2]-BSAcomplexes fixed a negligible amountofmouse C relative
to the anti-BSA (IgG)-BSA complexes in two independent experiments.
Because the anti-Ss heteroimmune serum was prepared by immunization with
an Ss preparation which was only partially purified, then made specific by
absorption with Ss-L serum, it was possible that there could be a contaminating
antibody to a C component in the anti-Ss which was used for these experiments.
No such antibody could be detected by immunodiffusion or immunoelectro-
phoresis, but to rule out this possibility, an experiment similar to that shown in
Fig. 1 was carried out, but with addition of highly purified Ss protein to the
anti-Ss [F(ab'),] before addition to the mouse serum. The highly purified Ss
protein (kindly provided by T. Krasteff, Department of Human Genetics, Uni-
versity of Michigan, Ann Arbor, Mich., prepared by a method to be reported
later) completely neutralized the complement-depleting effect of anti-Ss
[F(ab')2]. Therefore it appears extremely unlikely that contaminating antibodies
were responsible for the results reported above.
Summary
A significant within-strain correlation has been demonstrated between the levels
of Ss and hemolytic complement (C) activity in two Ss-high strains. Mouse
serum specifically depleted of Ss by absorption with F(ab') 2 fragments ofanti-Ss
had negligible C activity. In control experiments, Ss-specific antigen-antibody
complexes formed with F(ab'), fragments did not fix rabbit C, and bovine serum
albumin-specific antigen-antibody complexes formed with F(ab') 2 fragments did
not fix mouse C. Therefore the removal of C activity by anti-Ss [F(ab'),] was
apparently not due to C fixation. These results suggest that the Ss protein is a
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